Free Trial

Avadel Pharmaceuticals (AVDL) SEC Filings & 10K Form

Avadel Pharmaceuticals logo
$11.97 -0.05 (-0.42%)
(As of 11:22 AM ET)

Recent Avadel Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/12/2024
6:06 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
6:07 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
9:34 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:18 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:01 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
8:25 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:12 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:31 PM
Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:32 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:35 PM
Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:36 PM
Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:37 PM
Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:38 PM
Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:12 PM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
6:25 AM
Avadel Pharmaceuticals (Filer)
Form ARS
06/18/2024
6:17 AM
Avadel Pharmaceuticals (Filer)
Form DEFA14A
06/18/2024
6:11 AM
Avadel Pharmaceuticals (Filer)
Form DEF 14A
05/21/2024
4:27 PM
Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2024
4:29 PM
Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
6:04 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
8:16 AM
Avadel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
6:08 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
3:13 PM
Avadel Pharmaceuticals (Filer)
Form 10-K/A
04/15/2024
6:00 AM
Avadel Pharmaceuticals (Filer)
Form 8-A12B
04/15/2024
6:01 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:28 AM
Avadel Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:35 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:24 AM
Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:26 AM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:11 AM
Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2024
4:54 PM
Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
02/13/2024
8:40 AM
Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G
02/12/2024
7:20 AM
Avadel Pharmaceuticals (Subject)
KOTLER KEVIN (Filed by)
Form SC 13G/A
01/16/2024
3:36 PM
Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:20 AM
Avadel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:15 PM
Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
1:54 PM
Avadel Pharmaceuticals (Subject)
McCamish Mark Anthony (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AVDL) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners